4//SEC Filing
OPTIMER PHARMACEUTICALS INC 4
Accession 0001142576-09-000013
CIK 0001142576operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:40 PM ET
Size
8.8 KB
Accession
0001142576-09-000013
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2009-02-19+120,000→ 120,000 totalExercise: $10.85Exp: 2009-02-19→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on the year year anniversary of the vesting commencement date, and 1/48 of the total shares shall vest each month thereafter, subject to optionee continuing to be a service provider on each such date.
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeoperating
Related Parties
1- filerCIK 0001142576
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:40 PM ET
- Size
- 8.8 KB